Acurx Pharmaceuticals, DNA Polymerase IIIC, Pol IIIC Inhibitors, Antibiotic Research, Antimicrobial Resistance, Gut Microbiome, Microbiome Preservation, MRSA, Preclinical Research

Staten Island, New York, United States, October 21, 2026 Acurx Pharmaceuticals, Inc. has announced the publication of preclinical research...